Literature DB >> 22686169

Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.

Jayraan Badiee1, Patricia K Riggs, Alexandra S Rooney, Florin Vaida, Igor Grant, J Hampton Atkinson, David J Moore.   

Abstract

Assessing medication adherence in already difficult-to-treat HIV-infected subpopulations presents a unique challenge. The objective of this study was to compare different approaches to assessing medication adherence: (1) electronic medication monitoring, (2) standardized self-report questionnaire, and (3) self-report visual analogue scale, and to determine whether antiretroviral therapy (ART) adherence measures differed for HIV-infected persons with bipolar disorder (HIV+ /BD+) as compared to HIV-infected persons without bipolar disorder (HIV+ /BD-). ART adherence was assessed for 74 HIV-positive participants using the Medication Event Monitoring System (MEMS), AIDS Clinical Trials Group (ACTG) adherence questionnaire, and visual analogue scale (VAS). Participants were classified as adherent or nonadherent on each measure by previously validated cutscores. Correlations and logistic regressions were used to examine associations between adherence measures and demographic and clinical variables. In the HIV+ /BD- group, significant correlations existed between each self-report measure and the MEMS. Males comprised 81% of the study population. Participants averaged 44 years of age and 13 years of education. No significant correlations were found among adherence measures in the HIV+ /BD+ group. Among participants reporting adherence on either self-report measure but classified as nonadherent based on MEMS, 94% had a diagnosis of bipolar disorder. Bipolar disorder was a significant predictor of adherence classification discordance among self-report measures. Our findings suggest that it remains difficult to assess ART adherence among HIV-positive individuals with bipolar disorder. Combined approaches of self-report and objective measures may be the best way to estimate adherence, and may provide the best basis for interventions designed to improve adherence in difficult-to-treat populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22686169      PMCID: PMC3961000          DOI: 10.1089/apc.2011.0447

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  54 in total

1.  Nonadherence with mood stabilizers: prevalence and predictors.

Authors:  Jan Scott; Marie Pope
Journal:  J Clin Psychiatry       Date:  2002-05       Impact factor: 4.384

2.  Seroprevalence of HIV and risk factors for AIDS in psychiatric inpatients.

Authors:  M Sacks; H Dermatis; S Looser-Ott; S Perry
Journal:  Hosp Community Psychiatry       Date:  1992-07

3.  Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring.

Authors:  Andrew J Levine; Charles H Hinkin; Sarah Marion; Allison Keuning; Steven A Castellon; Mona M Lam; Marta Robinet; Douglas Longshore; Thomas Newton; Hector Myers; Ramani S Durvasula
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

4.  Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.

Authors:  Seth C Kalichman
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

5.  Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Melanie Lo; Saad B Omer; Leon Regensberg; Richard E Chaisson; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

6.  Survival and quality of life among HIV-positive people on antiretroviral therapy in Cambodia.

Authors:  Guy Morineau; Mean Chhi Vun; Hubert Barennes; Robert Cameron Wolf; Ngak Song; Dimitri Prybylski; Natpratan Chawalit
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

7.  Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program.

Authors:  Jinmei Li; Jeffrey S McCombs; Glen L Stimmel
Journal:  J Affect Disord       Date:  2002-09       Impact factor: 4.839

8.  Better adherence with once-daily antiretroviral regimens: a meta-analysis.

Authors:  Jean-Jacques Parienti; David R Bangsberg; Renaud Verdon; Edward M Gardner
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

9.  Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.

Authors:  Thomas P Giordano; David Guzman; Richard Clark; Edwin D Charlebois; David R Bangsberg
Journal:  HIV Clin Trials       Date:  2004 Mar-Apr

10.  The five-site health and risk study of blood-borne infections among persons with severe mental illness.

Authors:  Stanley D Rosenberg; Jeffrey W Swanson; George L Wolford; Fred C Osher; Marvin S Swartz; Susan M Essock; Marian I Butterfield; Bryan J Marsh
Journal:  Psychiatr Serv       Date:  2003-06       Impact factor: 3.084

View more
  15 in total

1.  Youth Views on Communication About ADHD and Medication Adherence.

Authors:  Betsy Sleath; Delesha M Carpenter; Robyn Sayner; Kathleen Thomas; Larry Mann; Adam Sage; Sandra H Sulzer; Adrian D Sandler
Journal:  Community Ment Health J       Date:  2017-01-10

2.  Medication Adherence Among Adolescents with Bipolar Disorder.

Authors:  Tina R Goldstein; Megan Krantz; John Merranko; Matthew Garcia; Loren Sobel; Carlos Rodriguez; Antoine Douaihy; David Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-07-15       Impact factor: 2.576

Review 3.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.

Authors:  Mohamed El Alili; Bernard Vrijens; Jenny Demonceau; Silvia M Evers; Mickael Hiligsmann
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

Review 4.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.

Authors:  Alisha Monnette; Yichen Zhang; Hui Shao; Lizheng Shi
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

5.  Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.

Authors:  Robyn Sayner; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Annette L Giangiacomo; Gail Tudor; Betsy Sleath
Journal:  Clin Ther       Date:  2015-07-09       Impact factor: 3.393

6.  Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.

Authors:  David J Moore; Amelia Poquette; Kaitlin B Casaletto; Ben Gouaux; Jessica L Montoya; Carolina Posada; Alexandra S Rooney; Jayraan Badiee; Reena Deutsch; Scott L Letendre; Colin A Depp; Igor Grant; J Hampton Atkinson
Journal:  AIDS Behav       Date:  2015-03

7.  Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results.

Authors:  Robert L Cook; Kathleen M Weber; Dao Mai; Kathleen Thoma; Xingdi Hu; Babette Brumback; Manju Karki; Kendall Bryant; Mobeen Rathore; Mary Young; Mardge Cohen
Journal:  Contemp Clin Trials       Date:  2017-06-19       Impact factor: 2.226

8.  Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo.

Authors:  Robert L Cook; Zhi Zhou; Maria Jose Miguez; Clery Quiros; Luis Espinoza; John E Lewis; Babette Brumback; Kendall Bryant
Journal:  Alcohol Clin Exp Res       Date:  2019-07-10       Impact factor: 3.455

9.  Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients.

Authors:  Radhika Sreeraman; Srinivasan Vijayakumar; Allen M Chen
Journal:  Support Care Cancer       Date:  2013-07-28       Impact factor: 3.603

10.  Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities.

Authors:  Jennifer B Levin; Johnny Sams; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  Ther Adv Psychopharmacol       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.